Wandercraft has acquired Ekso Bionics from a subsidiary of ChronoScale Holdings, combining two major developers of robotic exoskeletons and mobility technology. Financial terms were not disclosed. The transaction brings together Wandercraft's physical AI and self-balancing robotics with Ekso's established U.S. clinical presence and two decades of experience developing wearable exoskeletons.
The combined company will support robotic mobility technologies across more than 700 rehabilitation and research centers worldwide, creating a larger clinical footprint spanning the U.S., Europe and other international markets. The portfolio covers both rehabilitation and personal mobility, providing technologies for patients affected by conditions including stroke, spinal cord injury, multiple sclerosis and acquired brain injury.
For clinical rehabilitation, the combined portfolio includes Wandercraft's Atalante X and EksoNR, which support upright standing and gait training in hospitals and rehabilitation centers. For personal mobility, Wandercraft's self-balancing Eve exoskeleton will sit alongside Ekso's lightweight Indego Personal system, offering different approaches for eligible individuals with spinal cord injuries who want greater upright mobility outside clinical environments.
The acquisition also expands Wandercraft's commercial and reimbursement infrastructure in the U.S. Eligible Medicare beneficiaries can access qualifying personal robotic exoskeletons through the Medicare brace benefit under HCPCS code K1007. Wandercraft plans to support patients and clinicians through the documentation, prior authorization, appeals and training processes required to access these technologies.
Strategically, Ekso's large North American clinical footprint also gives Wandercraft access to additional real-world mobility data that could support development of its physical AI technology. Wandercraft uses sensor and movement data to improve its balance, gait and robotic assistance algorithms, while also applying similar technologies beyond healthcare to industrial humanoid robotics.
Click here to read the original news story.
